GSK launches $2.5 billion buyback, lifts sales target after stellar fourth quarter
GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV ...
Hosted on MSN9d
GSK and Oxford researchers to create cancer vaccine to stop disease developing
“By exploring pre-cancer biology and building on GSK’s expertise in the science of the immune system ... Medicine to drive ...
Pharmabiz8d
GSK and University of Oxford establish the GSK-Oxford Cancer Immuno-Prevention Programme to advance novel cancer research
GSK plc and the University of Oxford (Oxford) announced that they have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The GSK-Oxford Cancer ...
Hosted on MSN8d
GSK and University of Oxford partner for cancer vaccine research
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...
emjreviews.com9d
GSK and Oxford unite to advance cancer vaccine research
The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.
PharmiWeb9d
GSK and Oxford establish the GSK-Oxford Cancer Immuno-Prevention Programme to advance novel cancer research
GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...